These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30555598)

  • 1. Lipid Polymer Hybrid Nanomaterials for mRNA Delivery.
    Zhao W; Zhang C; Li B; Zhang X; Luo X; Zeng C; Li W; Gao M; Dong Y
    Cell Mol Bioeng; 2018 Oct; 11(5):397-406. PubMed ID: 30555598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.
    Li B; Luo X; Deng B; Wang J; McComb DW; Shi Y; Gaensler KM; Tan X; Dunn AL; Kerlin BA; Dong Y
    Nano Lett; 2015 Dec; 15(12):8099-107. PubMed ID: 26529392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a Quality-By-Design Approach to Optimise Lipid-Polymer Hybrid Nanoparticles Loaded with a Splice-Correction Antisense Oligonucleotide: Maximising Loading and Intracellular Delivery.
    Thanki K; Papai S; Lokras A; Rose F; Falkenberg E; Franzyk H; Foged C
    Pharm Res; 2019 Jan; 36(3):37. PubMed ID: 30623253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
    Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
    Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and Optimization of Lipid-Like Nanoparticles for mRNA Delivery.
    Li B; Dong Y
    Methods Mol Biol; 2017; 1632():207-217. PubMed ID: 28730441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles.
    Yasar H; Biehl A; De Rossi C; Koch M; Murgia X; Loretz B; Lehr CM
    J Nanobiotechnology; 2018 Sep; 16(1):72. PubMed ID: 30231888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering of budesonide-loaded lipid-polymer hybrid nanoparticles using a quality-by-design approach.
    Leng D; Thanki K; Fattal E; Foged C; Yang M
    Int J Pharm; 2018 Sep; 548(2):740-746. PubMed ID: 28847667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-functional lipid-like nanoparticles for delivery of mRNA and MRI contrast agents.
    Luo X; Li B; Zhang X; Zhao W; Bratasz A; Deng B; McComb DW; Dong Y
    Nanoscale; 2017 Jan; 9(4):1575-1579. PubMed ID: 28067926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol.
    Thanki K; Zeng X; Foged C
    Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised lipid-polymer hybrid nanoparticles for the delivery of a therapeutic anti-inflammatory microRNA to bronchial epithelial cells.
    Vencken S; Foged C; Ramsey JM; Sweeney L; Cryan SA; MacLoughlin RJ; Greene CM
    ERJ Open Res; 2019 Apr; 5(2):. PubMed ID: 30972350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local anesthetic effects of bupivacaine loaded lipid-polymer hybrid nanoparticles: In vitro and in vivo evaluation.
    Ma P; Li T; Xing H; Wang S; Sun Y; Sheng X; Wang K
    Biomed Pharmacother; 2017 May; 89():689-695. PubMed ID: 28267672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(lactide-
    Wu L; Wu LP; Wu J; Sun J; He Z; Rodríguez-Rodríguez C; Saatchi K; Dailey LA; Häfeli UO; Cun D; Yang M
    ACS Appl Mater Interfaces; 2021 Jan; 13(3):3722-3737. PubMed ID: 33439616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration.
    Ni R; Huang L; Li Z; Zhang W; Wang Y; Shen Y; Wang J; Lu W
    Int J Nanomedicine; 2022; 17():5883-5897. PubMed ID: 36478745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-detachable lipid-polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells.
    Du JB; Song YF; Ye WL; Cheng Y; Cui H; Liu DZ; Liu M; Zhang BL; Zhou SY
    Anticancer Drugs; 2014 Aug; 25(7):751-66. PubMed ID: 24590167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing.
    Zhang X; Zhao W; Nguyen GN; Zhang C; Zeng C; Yan J; Du S; Hou X; Li W; Jiang J; Deng B; McComb DW; Dorkin R; Shah A; Barrera L; Gregoire F; Singh M; Chen D; Sabatino DE; Dong Y
    Sci Adv; 2020 Aug; 6(34):. PubMed ID: 32937374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells.
    Küçüktürkmen B; Devrim B; Saka OM; Yilmaz Ş; Arsoy T; Bozkir A
    Drug Dev Ind Pharm; 2017 Jan; 43(1):12-21. PubMed ID: 27277750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.